Editor | Curator

Advertisment

ATAI to Invest $50 Million in Beckley Psytech

-Strategic investment in Beckley Psytech reinforces atai’s position as the biopharmaceutical company with the largest and most diverse portfolio of clinical-stage psychedelic candidates -Two patent-protected,...

Psychedelic Support Team! The Fireside Project.

Fireside Project was born at a unique moment in history. It was the spring of 2020. The pandemic was raging. Depression, anxiety, and loneliness were at all-time highs. Calls to...

Blake Mycoskie Pledging $100 Million to Psychedelic Research (MarketWatch).

Donation is believed to be ‘biggest that we’ve ever seen in the psychedelics space.’ Quest for treatments for depression, PTSD centers on MDMA, psilocybin and similar drugs.

Free Psychedelic Help is Just a Call or Text Away! Fireside Project.

Interview with Hanifa Nayo Washington and Joshua White of Fireside Project. September 24th, 2021. If you were to poll every psychedelic user in the...

NRx Pharma (NRXP) Presentation at Sachs Neuroscience Forum.

Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, gives the keynote address "Ketamine for Suicidal Depression: The Benefits are Clear, but so are the Risks." Sachs...

Silo Pharma (SILO) Takes Aim at $3.1 Billion Fibromyalgia Market.

Silo dosage and time-release formulation aim for potential first at-home Ketamine therapeutic SARASOTA, FL, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the...

Psycheceutical’s (BWVI) Topical Ketamine: A Game-Changer for PTSD?

The cream targets NMDA receptors, like all ketamine administration routes. But it does so without entering the bloodstream. As a psychedelic enthusiast, I often err on the...

Psychedelic Happy Hour – Miami

Meet and Greet for Wonderland Miami Psychedelic Conference. November 10th. Guests will enjoy cocktails, music, and plenty of networking with...

Editor | Curator

Advertisment